Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics

The Lancet Neurology 2026

View at publisher

Authors: Jiwon Oh, Amit Bar-Or, Xavier Montalbán, Maria Pia Sormani, Martin S. Weber, Daniel S. Reich

DOI: 10.1016/s1474-4422(26)00141-9

Cited by: 1

References: 53

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Phagocytosis and Immune Regulation Protein Tyrosine Phosphatases

References 53